Tratamiento cancer renal pdf

Se autoriza el libre uso del texto de los documentos del PDQ. En Cancer. Tipos de tratamiento. Efectos secundarios. Medicina complementaria y alternativa. Preguntas para el doctor acerca del tratamiento. Su imagen propia y su sexualidad. Superar sus sentimientos. Instrucciones por adelantado. Uso de recursos fidedignos. Iniciativas clave. Comunicados de prensa.

Blog Temas y relatos. Buscar Buscar. Tratamiento del tumor de Wilms y otros tumores renales infantiles. Uso inapropiado y durante mucho tiempo de ciertos medicamentos , incluso los medicamentos para el dolor que son de venta libre. Sangre en la orina. Masa en el abdomen. Dolor a un costado que no desaparece. Los ecos forman una imagen de los tejidos del cuerpo que se llama ecograma. Una cantidad anormal mayor o menor que la normal de una sustancia suele ser un signo de enfermedad.

Estadio de la enfermedad. Edad y estado general de salud del paciente. A veces se necesitan pruebas de seguimiento. El ipilimumab es un tipo de inhibidor de CTLA Kim-Schulze, M.

Panelli, et al. Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.

J Clin Oncol, 27 , pp. Li, G. Feng, A. Gentil-Perret, et al. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional re-nal cell cancer. Zhao, B. Ljungberg, K. Grankvist, et al. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med, 3 , pp. Sorbellini, M. Kattan, M. Snyder, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. Zisman, A. Pantuck, F.

Dorey, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol, 19 , pp. Frank, M. Blute, J. Cheville, et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. Leibovich, M. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: A stratification tool for prospective clinical trials.

Cancer, 97 , pp. Patard, H. Kim, J. Lam, et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: An international multicenter study. J Clin Oncol, 22 , pp.

Karakiewicz, A. Briganti, F. Chun, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol, 25 , pp. Zigeuner, G.

Hutterer, T. Chromecki, et al. External validation of the Mayo Clinic stage, size, grade, and necrosis SSIGN score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Eur Urol, 57 , pp. World Health Organization Classification of Tumours. Moch, M. Amin, et al. Sarcomatoid differentiation in renal cell carcinoma: A study of cases.

Am J Surg Pathol, 25 , pp. Molina, S. Tickoo, N. Ishill, et al. Sarcomatoid-variant renal cell carcinoma: Treatment outcome and survival in advanced disease. Am J Clin Oncol, 34 , pp. Kuroda, C. Ohe, S. Mikami, et al. Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects.

Histol Histopathol, 27 , pp. Webster, R. Thompson, J. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology, 70 , pp. Gong, N. Zhang, Z. He, et al. Multilocular cystic renal cell carcinoma: An experience of clinical management for 31 cases. J Cancer Res Clin Oncol, , pp.

Ishihara, Y. Yamashita, H. Takamori, et al. Renal carcinoma with 6;11 p21;q12 translocation: Report of an adult case. Pathol Int, 61 , pp. Hes, M. Hora, D. Perez-Montiel, et al. Histopathol, 41 , pp. Hes, T. Reischig, et al. Transplant Proc, 40 , pp. Neuzillet, X. Tillou, R. Renal cell carcinoma RCC in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

Eur Urol, 60 , pp. Gigante, Y. Neuzillet, J. Renal cell carcinoma RCC arising in native kidneys of dialyzed and transplant patients: Are they different entities?.

Tickoo, M. Harik, et al. Spectrum of epithelial neoplasm in end-stage renal disease: An experience from 66 tumor-bearing kidneys with emphasis on histological pattern distinct from those in sporadic adult renal neoplasia.

Am J Surg Pathol, 30 , pp. Aydin, L. Chen, L. Cheng, et al. Clear cell tubulopapillary renal cell carcinoma: A study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol, 34 , pp. Kurup, R. Renal oncocytoma growth rates before intervention. Kawaguchi, K.

Fernandes, A. Finelli, et al. Most renal oncocytomas appear to grow: Observations of tumor kinetics with active surveillance. Mues, J. Palacios, G. Haramis, et al. Contemporary experience in the management of angiomyolipoma. J Endourol, 24 , pp. Ramon, U. Rimon, A. Garniek, et al. Renal angiomyolipoma: Long-term results following selective arterial embolization. Eur Urol, 55 , pp. Nelson, M. Contemporary diagnosis and management of renal angiomyolipoma.

Oesterling, E. Fishamn, S. Goldman, et al. Butler, A. Novick, D. Miller, et al. Management of small unilateral renal cell carcinomas: Radical vs. Urology, 45 , pp. Gratzke, M. Seitz, F. Bayrle, et al. Quality of life and perioperative outcomes after retro-peritoneoscopic radical nephrectomy RN , open RN and nephron-sparing surgery in patients with renal cell carcinoma. Damiano, B. Feleppa, et al. Elective conservative surgery for renal carcinoma vs.

Br J Urol, 79 , pp. Lee, C. You, G. Min, et al. Comparison of the surgical outcome and renal function between radical and nephron-sparing surgery for renal cell carcinomas.

Korean J Urol, 48 , pp. Van Poppel, L. Albrecht, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol, 59 , pp. Huang, E. Elkin, A. Levey, et al. Partial nephrectomy vs. Zini, P. Perrotte, U. Capitanio, et al. Radical vs. Cancer, , pp. Thompson, S. Boorjian, C. Lohse, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.

Patard, K. Bensalah, A. Pantuck, et al. Eur Urol Suppl, 7 , pp. Jang, Y. Park, S. Oncologic and functional outcomes after partial nephrectomy vs. Shekarriz, J. Upadhyay, H. Shekarriz, et al. Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma.

Urology, 59 , pp. Dash, A. Vickers, L. Schachter, et al. Comparison of outcomes in elective partial vs. BJU Int, 97 , pp. Simmons, C. Weight, I. Laparosco-pic radical vs. Urology, 73 , pp. Poulakis, U. Witzsch, R. Quality of life after surgery for localized renal cell carci-noma: Comparison between radical nephrectomy and nephron-sparing surgery. Urology, 62 , pp. Takaki, K. Yamakado, N. Soga, et al. Midterm results of radiofrequency ablation vs.

Jpn J Radiol, 28 , pp. Lane, H. Tiong, S. Campbell, et al. Management of the adrenal gland during partial nephrectomy. Blom, H. Capitanio, F. Becker, M. Blute, et al.

Lymph node dissection in renal cell carcinoma. Herrlinger, K. Schrott, G. Schott, et al. What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma.

Chapin, S. Delacroix Jr. The role of lymph node dissection in renal cell carcinoma. Int J Clin Oncol, 16 , pp. Maxwell, N. Saleem Amer, E. Rogers, et al. Renal artery embolization in the palliative treatment of renal carcinoma. Br J Radiol, 80 , pp. Hallscheidt, S. Besharati, G. Noeldge, et al. Preoperative and palliative embolization of renal cell carcinomas: Follow-up of 49 patients.

Rofo, , pp. Lamb, E. Bromwich, P. Vasey, et al. Management of renal masses in patients medically unsuitable for nephrectomy—natural history, complications and outcome. Urology, 64 , pp. Kickuth, C. Waldherr, H. Hoppe, et al. Interventional management of hypervascular osseous metastasis: Role of embolotherapy before orthopedic tumor resection and bone stabilization. Forauer, E. Kent, W. Cwikiel, et al. Selective palliative transcatheter embolization of bony metastases from renal cell carcinoma.

Acta Oncol, 46 , pp. Hemal, A. Kumar, R. Kumar, et al. Laparoscopic vs. Brewer, R. Hayn, et al. Perioperative and renal function outcomes of minimally invasive partial nephrectomy for T1b and T2a kidney tumors. J Endourol, 26 , pp.

Sprenkle, N. Power, T. Ghoneim, et al. Comparison of open and minimally invasive partial nephrectomy for renal tumors centimeters.

Eur Urol, 61 , pp. Peng, J. Zheng, D. Xu, J. Retroperitoneal laparoscopic nephrectomy and open nephrectomy for radical treatment of renal cell carcinoma: A comparison of clinical outcomes. Nadler, S. Loeb, J. Clemens, et al. A prospective study of laparoscopic radical nephrectomy for T1 tumors—is transperitoneal, retroperitoneal or hand assisted the best ap-proach?.

A prospective comparison of laparoscopic and robotic radical nephrectomy for TN0M0 renal cell carcinoma. World J Urol, 27 , pp. Soga, M. Kato, S. Masui, et al. Comparison of radical nephrectomy techniques in one center: Minimal incision portless endoscopic surgery vs. Int J Urol, 15 , pp. Ku, et al. Laparoendoscopic single-site radical nephrectomy for localized renal cell carcinoma: Comparison with conventional laparoscopic surgery.

J Endourol, 23 , pp. Gill, L. Kavoussi, B. Lane, et al. Comparison of 1, laparoscopic and open partial nephrectomies for single renal tumors. Tugcu, A. Bitkin, E. Sonmezay, et al. Transperitoneal vs. Arch Ital Urol Androl, 83 , pp. Masson-Lecomte, K. Seringe, et al. A prospective comparison of surgical and pathological outcomes obtained after robot-assisted or pure laparoscopic partial nephrectomy in moderate to complex renal tumours: Results from a French multicentre collaborative study.

Aboumarzouk, R. Stein, R. Eyraud, et al. Robotic vs. Bi, C. Zhang, K. Robotic partial nephrectomy for renal tumors larger than 4 cm: A systematic review and meta-analysis. PLoS One, 8 , pp.